Loading
TH
Third Harmonic Bio, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 22 Dec 2022.
Third Harmonic Bio, Inc.: what insiders have been doing
Every trade that managers of Third Harmonic Bio, Inc. disclose to SEC (Form 4) is tracked on this page. The past year has been quiet: not a single insider filing for Third Harmonic Bio, Inc. The previous disclosure was published on 14 August 2025.
Other companies in the same market with recent insider buying flagged by our signals: Relmada Therapeutics, Inc. and Uber Technologies, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
23
Thresholds
n/a
Buy Volume
€451,460
1 ops. · all time
Sell Volume
€7M
1 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Last declaration on 14 August 2025
Declarations23 total
1,218,836 sharesCommon StockSEC:0001415889-25-021825:0
128,631 sharesCommon StockSEC:0001415889-25-021822:0
85,753 sharesCommon StockSEC:0001415889-25-021821:0
5,779,071 sharesCommon StockSEC:0001415889-25-021818:0
2,117 shares@ US$4.2014.9% of flowCommon StockSEC:0001415889-24-026626:0
515,688 shares0Common StockSEC:0001415889-24-026125:0
538,420 shares@ US$14.3094.0% of flowCommon StockSEC:0000921895-24-002409:0
2,673 shares@ US$4.2018.8% of flowCommon StockSEC:0001415889-24-025750:0
503 shares@ US$4.202.0% of flowCommon StockSEC:0001415889-24-023787:0
4,790 shares@ US$4.2032.6% of flowCommon StockSEC:0001415889-24-023788:0
10,000 shares@ US$4.2041.2% of flowCommon StockSEC:0001415889-24-018457:0
494 shares@ US$4.202.6% of flowCommon StockSEC:0001415889-24-016218:0
1,042 shares@ US$4.305.7% of flowCommon StockSEC:0001415889-24-014103:0
16,666 shares@ US$4.3091.6% of flowCommon StockSEC:0001415889-24-013755:0
20,222 shares@ US$4.2059.7% of flowCommon StockSEC:0001415889-24-012841:0
13,558 shares@ US$4.2040.3% of flowCommon StockSEC:0001415889-24-010808:0
1,107 shares@ US$4.204.5% of flowCommon StockSEC:0001415889-24-010512:0
4,790 shares@ US$4.2033.6% of flowCommon StockSEC:0001209191-23-057712:0
12,863 shares@ US$4.2052.3% of flowCommon StockSEC:0001209191-23-057714:0
116,635 shares@ US$4.10866.0% of flowCommon StockSEC:0001193805-22-001774:0
Canonical exit: 20 Mar 2023 (T+90)
5,479,071 sharesCommon StockSEC:0001209191-22-050938:0
5,479,071 sharesCommon StockSEC:0001209191-22-050937:0
6,472,374 sharesCommon StockSEC:0001209191-22-050535:0
23 of 23 declarations
About Third Harmonic Bio, Inc.
Third Harmonic Bio, Inc. is a biopharmaceutical company focused on developing innovative therapies for immunological diseases. It is listed on NASDAQ under the ticker THRD.
